文献速递腹部泌尿生殖CT

灌注CT测量预测直肠癌肿瘤治疗反应

Perfusion CT measurements predict tumor response in rectal carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2017-01-01

这项前瞻性研究纳入17例直肠癌患者,在放化疗前、开始后1-2周及开始后12周行灌注CT,分别以「热点」法和全肿瘤法测量灌注参数。单因素分析显示血容量和渗透性在反应者与非反应者间有显著差异;逻辑回归中仅热点血容量峰值(OR 10.25,p=0.0026)和12周时热点渗透性下降(OR 5.62,p=0.03)为完全病理反应的显著预测因子。

要点

  • 热点法测量的肿瘤血容量峰值和渗透性下降可预测直肠癌新辅助治疗后的完全反应。
  • 热点血容量峰值(治疗1-2周)OR 10.25(p=0.0026),热点渗透性下降(12周)OR 5.62(p=0.03)。
  • 单因素分析中血容量和渗透性在反应者与非反应者间差异显著。

核心结论

  • 热点法测量的肿瘤血容量峰值和肿瘤渗透性下降是新辅助治疗后直肠癌完全治疗反应的强预测因子。

研究设计与样本

  • 前瞻性、经IRB批准的研究,共纳入17例直肠癌患者。
  • 每例患者在放化疗开始前、开始后1-2周及开始后12周各行一次灌注CT采集。
  • 每个数据集以两种方式测量三个灌注参数:仅包含强化最明显「热点」的感兴趣区法和全肿瘤测量法。

诊断标准与关键数值

  • 单因素分析中血容量和渗透性在反应者与非反应者间差异显著。
  • 逻辑回归评估「完全反应」结局的预测因子,仅热点血容量峰值(治疗1-2周,OR 10.25,p=0.0026)和热点渗透性下降(治疗开始后12周,OR 5.62,p=0.03)保留为统计学显著。
  • 该模型总体似然比检验支持热点血容量和热点渗透性下降为完全病理反应结局的显著预测因子(p<0.0001)。

局限性

  • 原文称本研究为初步研究(pilot study)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the capacity of perfusion CT imaging to distinguish between complete and incomplete responders after neoadjuvant chemoradiation therapy for rectal carcinoma, with particular attention to segmentation technique.

MATERIALS AND METHODS: 17 patients were evaluated in this prospective IRB-approved study. For each patient, a perfusion CT acquisition was obtained prior to the initiation of chemoradiation, at 1-2 weeks after the start of chemoradiation, and at 12 weeks after the start of chemoradiation therapy. From each dataset, three perfusion parameters were measured, each in two different ways: a region of interest incorporating only "hot spots" of greatest enhancement and whole-tumor measurements.

RESULTS: In univariate analysis, blood volume and permeability differed significantly between responders and non-responders. In logistic regression analysis evaluating predictors of the "complete response" outcome, only two predictors were retained as statistically significant: peak hot spot blood volume 1-2 weeks into therapy (OR 10.25, p = 0.0026) and hot spot permeability decline at 12 weeks after the initiation of therapy (OR 5.62, p = 0.03). The overall likelihood ratio test for this model supported the conclusion that hot spot blood volume and hot spot permeability decline were significant predictors of the complete pathologic response outcome (p < 0.0001).

CONCLUSION: In this pilot study, peak tumor blood volume and decline in tumor permeability, when measured in "hot spots" of greatest enhancement, were strong predictors of complete therapeutic response in rectal cancer after neoadjuvant therapy.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kino A, Shaffer J, Maturen KE, et al. Perfusion CT measurements predict tumor response in rectal carcinoma. Abdom Radiol (NY). 2017. PMID: 28008455. doi:10.1007/s00261-016-0983-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。